Clinical Trials Logo

Glucose, High Blood clinical trials

View clinical trials related to Glucose, High Blood.

Filter by:

NCT ID: NCT03627923 Recruiting - Diet Habit Clinical Trials

Personalizing Mediterranean Diet in Children.

Start date: December 27, 2018
Phase:
Study type: Observational

Investigating glucose response to Mediterranean and regular diets in healthy children in order to develop specific pediatric machine-learning for predicting the personalized glucose response to food for individual children. The prediction will be based on multiple measurements, including blood tests, personal lifestyle and gut microbiome. This will allow investigators to design personalized Mediterranean machine-learning-based diets which may potentially reduce the burden of disease in adulthood as well as the burden of obesity in the pediatric age.

NCT ID: NCT03566511 Suspended - Clinical trials for Diabetes Mellitus, Type 2

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

Start date: June 12, 2018
Phase: Phase 2
Study type: Interventional

The goal of this study is to determine whether metabolic control centers in the brain can be activated in patients with type 2 diabetes as compared to non-diabetic individuals. This is important since people with diabetes have inappropriately high production of glucose, which could be at least in part due to impaired activation of important brain centers.

NCT ID: NCT03544411 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM

Start date: July 2, 2018
Phase: Phase 1
Study type: Interventional

This study determines the effect of olive oil and bran oil on antioxidant levels, and glycemic control in patients with type 2 diabetes mellitus (DM) Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study

NCT ID: NCT03540758 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Regulation of Endogenous Glucose Production by Central KATP Channels

Start date: August 1, 2018
Phase: Phase 2
Study type: Interventional

Type 2 diabetes affects the ability of the body to process glucose (sugar). Under fasting conditions, the liver is able to make sugar to maintain glucose levels in an important process called endogenous glucose production (EGP). Previous studies suggest that the central nervous system (CNS), including the brain, helps to regulate levels of glucose in the body by communicating with the liver. This process can be impaired in people with type 2 diabetes, and can contribute to the high level of glucose seen in these individuals. The purpose of this study is to understand how activating control centers of the brain with a medication called diazoxide can affect how much glucose (sugar) is made by the liver. This is particularly important for people with diabetes who have very high production of glucose, which in turn can lead to diabetes complications.

NCT ID: NCT03458494 Active, not recruiting - Type2 Diabetes Clinical Trials

The TCF7L2 Gene: Dietary Prevention of T2DM

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

Nutrients and chemicals in food are able to regulate expression of genetic elements. Gene-nutrient interaction in response specific diets can increase an individual's risk, shifting the individual from health toward the development of chronic disease. The Transcription Factor 7 Like 2 (TCF7L2) gene may either put individuals at risk for or protect from Type 2 diabetes mellitus in the presence of certain foods. The main purpose of this four-week study is to examine diet-induced gene-nutrient interaction, with a focus on glucose, insulin, inflammation (CRP) and the plasma metabolome in individuals who have either the CC or the TT form of the rs7903146 single nucleotide polymorphism (SNP) (C/T) within the TCF7L2 gene. The (2) one-week study diets, one Mediterranean diet (MedDiet) based and the other low-fat based will be separated by a (1) week return to a regular habitual diet.

NCT ID: NCT03428295 Suspended - Glucose, High Blood Clinical Trials

Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

Start date: June 22, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to test two different operating modes of the latest version of the Dose Safety artificial pancreas system (APS), the Dose Safety Controller (DSC version 2.3), in a population of subjects with type 1 diabetes (TID) in a hospital CRC setting. The first mode is the Fully Automated Closed Loop (FACL) mode, in which all insulin delivery is directed by the controller and the second mode is the Hybrid Closed Loop (HCL) mode, in which insulin delivery is a hybrid between controller directed delivery and user directed insulin delivery. There will be two study arms: HCL and FACL. No comparisons will be made between the two arms.

NCT ID: NCT03422848 Recruiting - Glucose, High Blood Clinical Trials

Hydration to Optimize Metabolism

H2O-metabolism
Start date: April 24, 2018
Phase: N/A
Study type: Interventional

This study evaluates hydration (1.5 L of water daily during 1 year) in the lowering of blood glucose concentration in adults with signs of dehydration (elevated levels of the vasopressin marker copeptin and high urine osmolality). Half of participants will in addition to lifestyle advice receive extra water on top of their habitual fluid intake, and the other half (control) will receive only lifestyle advice.

NCT ID: NCT03346746 Completed - Mood Clinical Trials

Utilizing GI: Exploring an Optimum Glycaemic Profile for Cognitive Function Across the Day

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

This study provides participants with two diets that vary in their glycaemic index values (low vs. high), whilst also measuring cognitive performance and mood.

NCT ID: NCT03344185 Completed - Mood Clinical Trials

The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day

Start date: July 2016
Phase: N/A
Study type: Interventional

This study provided 24 healthy subjects with two diets that varied in their glycaemic index values. One condition was a low GI diet, whilst the other was a high GI diet. Glucose concentrations and mood were measured throughout each test day.

NCT ID: NCT03252704 Completed - Glucose, High Blood Clinical Trials

Post-prandial Glycemic Response to Fiber in Healthy Adults

Start date: March 31, 2016
Phase: N/A
Study type: Interventional

This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.